P-165 Efficacy and toxicity of FOLFIRI / aflibercept in second line colorectal cancer in real life population, retrospective study. Does first line matter?

מאת Fernandez Montes, A., Martinez Lago, N., Covela Rúa, M., De la Cámara Gómez, J., Méndez Méndez, J.C., Gonzalez Villarroel, P.
הוצא לאור ב Ann Oncol (2016)

Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept

מאת González Astorga, B., Salvà Ballabrera, F., Aranda Aguilar, E., Élez Fernández, E., García-Alfonso, P., González Flores, E., Vera García, R., Fernández Montes, A., López Muñoz, A. M., Salud Salvia, A.
הוצא לאור ב Clin Transl Oncol (2021)

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of tra...

מאת Custodio, A, Carmona-Bayonas, A, Jiménez-Fonseca, P, Sánchez, M L, Viudez, A, Hernández, R, Cano, J M, Echavarria, I, Pericay, C, Mangas, M, Visa, L, Buxo, E, García, T, Rodríguez Palomo, A, Álvarez Manceñido, F, Lacalle, A, Macias, I, Azkarate, A, Ramchandani, A, Fernández Montes, A, López, C, Longo, F, Sánchez Bayona, R, Limón, M L, Díaz-Serrano, A, Hurtado, A, Madero, R, Gómez, C, Gallego, J
הוצא לאור ב Br J Cancer (2017)